Bibliographies thématiques / Antineoplastic agents

Sommaire

  1. Articles de revues
  2. Thèses
  3. Livres
  4. Chapitres de livres
  5. Actes de conférences
  6. Rapports d'organisations

Littérature scientifique sur le sujet « Antineoplastic agents »

Auteur : Grafiati
Publié le 4 juin 2021
Mis à jour le 25 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Antineoplastic agents ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Antineoplastic agents"

1

Carlson, Patricia A. "Antineoplastic agents." Critical Care Nursing Quarterly 18, no. 4 (1996): 1–15. http://dx.doi.org/10.1097/00002727-199602000-00002.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Menta, Ernesto, and Manlio Palumbo. "Novel antineoplastic agents." Expert Opinion on Therapeutic Patents 7, no. 12 (1997): 1401–26. http://dx.doi.org/10.1517/13543776.7.12.1401.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Menta, Ernesto, and Manlio Palumbo. "Antineoplastic agents 1998." Expert Opinion on Therapeutic Patents 8, no. 12 (1998): 1627–72. http://dx.doi.org/10.1517/13543776.8.12.1627.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Pettit, G. R., Y. Kamano, R. Aoyagi, et al. "Antineoplastic agents 100." Tetrahedron 41, no. 6 (1985): 985–94. http://dx.doi.org/10.1016/s0040-4020(01)96466-x.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Bukowski, Ronald M. "Novel antineoplastic agents." Current Oncology Reports 2, no. 1 (2000): 9–10. http://dx.doi.org/10.1007/s11912-000-0004-1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Hong, Samuel J., Edward C. Li, Linda M. Matusiak, and Glen T. Schumock. "Spending on Antineoplastic Agents in the United States, 2011 to 2016." Journal of Oncology Practice 14, no. 11 (2018): e683-e691. http://dx.doi.org/10.1200/jop.18.00069.

Texte intégral
Résumé :
Purpose: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system. There is little information on recent trends in actual antineoplastic expenditures representative of the whole US health care system or by sector. Therefore, the objective of this study was to describe antineoplastic expenditures in the United States by year and sector. Methods: This was a retrospective, cross-sectional study of IQVIA (formerly QuintilesIMS) National Sales Perspective data for the period of Jan
Styles APA, Harvard, Vancouver, ISO, etc.
7

DOLL, DONALD C., Q. SCOT RINGENBERG, and JOHN W. YARBRO. "Antineoplastic Agents and Pregnancy." Obstetrical & Gynecological Survey 45, no. 6 (1990): 376. http://dx.doi.org/10.1097/00006254-199006000-00008.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Pettit, George R., Noeleen Melody, and Jean-Charles Chapuis. "Antineoplastic Agents. 605. Isoquinstatins." Journal of Natural Products 81, no. 3 (2017): 451–57. http://dx.doi.org/10.1021/acs.jnatprod.7b00352.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Hussain, M. A. ha, A. N. toinette J. Wozniak, and M. A. rk B. Edelstein. "Neurotoxicity of antineoplastic agents." Critical Reviews in Oncology/Hematology 14, no. 1 (1993): 61–75. http://dx.doi.org/10.1016/1040-8428(93)90006-p.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Castells, M. "Hypersensitivity to Antineoplastic Agents." Current Pharmaceutical Design 14, no. 27 (2008): 2892–901. http://dx.doi.org/10.2174/138161208786369803.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Thèses sur le sujet "Antineoplastic agents"

1

Wan, Jung Wing. "Novel ether lipids as antineoplastic agents." Thesis, University of Southampton, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.242627.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Molyneux, Gemma. "Studies on the haemotoxicity of antineoplastic agents." Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.435080.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Chen, Alina. "New polyamine analogues as potential antineoplastic agents." Scholarly Commons, 2000. https://scholarlycommons.pacific.edu/uop_etds/2680.

Texte intégral
Résumé :
The naturally occurring polyamines play an essential role in cell growth and proliferation. The levels of polyamines have been shown to increase in rapidly proliferating cancer cells. Therefore, compounds that inhibit enzymes in polyamine biosynthetic pathway may have therapeutic potential. Compounds capable of providing both in vitro and in vivo inhibition of almost all enzymes in the polyamine biosynthetic pathway are known. An exception is the lack of an agent that inhibits spermidine/spermine N 1 -acetyltransferase (SSAT), the rate-limiting enzyme in the catabolism of polyamines. The desig
Styles APA, Harvard, Vancouver, ISO, etc.
4

Ganley, Brian. "Investigations into the chemical mechanisms of biological activity by heterocyclic di-N-oxides and 1,2 benzodithiolan-3-one 1-oxides." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999285.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Ramirez, Daniel A. Kane Robert R. "Synthesis of protected amino thymidines and new thiol derivatives of the vascular targeting agent combretastatin A-4." Waco, Tex. : Baylor University, 2006. http://hdl.handle.net/2104/5008.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Ganley, Brian Christopher. "Investigations into the chemical mechanisms of biological activity by heterocyclic di-N-oxides and 1,2 benzodithiolan-3-one 1-oxides /." free to MU campus, to others for purchase, 2000. http://wwwlib.umi.com/cr/mo/fullcit?p9999285.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Reese, Michael. "Drug design (STAT5 modulators), development (Glyceollin I) and improvement (Esmolol Plus) /." Connect to full text in OhioLINK ETD Center, 2009. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=toledo1265033116.

Texte intégral
Résumé :
Thesis (M.S.)--University of Toledo, 2009.<br>Typescript. "Submitted as partial fulfillment of the requirements for the Master of Science Degree in Medicinal Chemistry." "A thesis entitled"--at head of title. Bibliography: leaves 45-48.
Styles APA, Harvard, Vancouver, ISO, etc.
8

Kanyanda, Stonard Sofiel Elisa. "Screening of natural products and Alkylating agents for Antineoplastic Activity." Thesis, University of the Western Cape, 2007. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_6433_1363357514.

Texte intégral
Résumé :
<p>Background and objectives: Apoptosis is a process in which a cell programmes its own death. It is a highly organized physiological mechanism in which injured or damaged cells are destroyed. Apart from physiological stimuli however, exogenous factors can induce apoptosis. Many anti-cancer drugs work by activating apoptosis in cancer cells. Natural substances have been found to have the ability to induce apoptosis in various tumour cells and these substances have been used as templates for the construction of&nbsp<br>novel lead compounds in anticancer treatment. On the other hand, alkylating
Styles APA, Harvard, Vancouver, ISO, etc.
9

Parker-, Johnson Kitani A. "An evaluation of novel antineoplastic agent on prostate cancer." DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 2003. http://digitalcommons.auctr.edu/dissertations/3074.

Texte intégral
Résumé :
This study examines the effects of novel antineoplastic agents(isochalcones) on human metastatic prostate cancer cell lines by screening cells for their relative antiproliferative effects, measuring the protein expression levels of specific oncogenes by Western blotting, and evaluating an array of genes ( 5184) to determine possible mechanisms of action of these novel isochalcones. The array data were supported by real-time polymerase chain reaction (PCR) techniques. The antineoplastic agents were screened in human metastatic prostate cancer cell lines (LNCaP, DU145, PC-3, and MDA-PCa-2b) and
Styles APA, Harvard, Vancouver, ISO, etc.
10

Lin, Tung Yin. "Synthetic studies towards the stellettins /." View online, 2008. http://repository.eiu.edu/theses/docs/32211131443971.pdf.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Livres sur le sujet "Antineoplastic agents"

1

Milne, George W. A., 1937-, ed. Ashgate handbook of antineoplastic agents. Ashgate, 2000.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

David, Goldman I., ed. Membrane transport of antineoplastic agents. Pergamon Press, 1986.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

1932-, Borders Donald B., and Doyle Terrence W. 1942-, eds. Enediyne antibiotics as antitumor agents. M. Dekker, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

E, Wittes Robert, and National Cancer Institute (U.S.), eds. Compilation of phase II results with single antineoplastic agents. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, 1986.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

V, Wilman Derry E., ed. The chemistry of antitumour agents. Blackie, 1990.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

David, Kessel, ed. Resistance to antineoplastic drugs. CRC Press, 1989.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

A, Valeriote Frederick, Corbett Thomas H, and Baker Lawrence H, eds. Anticancer drug discovery and development: Natural products and new molecular models : proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27-29, 1991. Kluwer Academic Publishers, 1994.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Chow, Nang-Ly. Liposomes as carriers of antineoplastic agents and immunomodulators. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1989.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

National Institutes of Health (U.S.), ed. Compilation of phase II results with single antineoplastic agents. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1985.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC, 2000.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Chapitres de livres sur le sujet "Antineoplastic agents"

1

O'brien, Wendy Pott. "Antineoplastic Agents." In Physiologically Based Pharmacokinetic Modeling. John Wiley & Sons, Inc., 2005. http://dx.doi.org/10.1002/0471478768.ch11.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Patsalos, P. N. "Antineoplastic Agents." In Antiepileptic Drug Interactions. Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2434-4_57.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Patsalos, Philip N. "Antineoplastic Agents." In Antiepileptic Drug Interactions. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32909-3_61.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Kirschenbaum, Harold L., and Michelle M. Kalis. "Antineoplastic Agents." In The Pharmacy Practice Handbook of Medication Facts. Routledge, 2023. http://dx.doi.org/10.4324/9780429272783-7.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Patsalos, Philip N. "Antineoplastic Agents." In Antiseizure Medication Interactions. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82790-8_68.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Schmähl, D., M. R. Berger, B. K. Keppler, and T. Klenner. "New Antineoplastic Agents." In Cancer Therapy. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74683-3_11.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Bloch, Alexander. "Antineoplastic Agents and Cancer Cell Differentiation." In Cancer Biology and Therapeutics. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-9564-6_15.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Jack, David B. "Pharmacokinetic data on antineoplastic and immunosuppressant agents." In Handbook of Clinical Pharmacokinetic Data. Palgrave Macmillan UK, 1992. http://dx.doi.org/10.1007/978-1-349-22495-1_14.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Balis, Frank M. "The pharmacology of antineoplastic agents in children." In The Role of Pharmacology in Pediatric Oncology. Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-4267-7_2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Berger, Martin R. "Experiments on the Carcinogenic Potential of Antineoplastic Agents." In Late Sequelae in Oncology. Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-46794-3_34.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Antineoplastic agents"

1

Alonso Castro, V., B. López Centeno, I. Martín Casasempere, et al. "4CPS-105 Prescribed antineoplastic agents in paediatric patients." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.254.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Yoon, Seug Yun, Namsu Lee, Sook-Ja Kim, Hee-Jeong Cheong, Kyoung Ha Kim, and Jong-Ho Won. "Abstract 3843: Pulmonary toxicities of molecular targeted antineoplastic agents." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3843.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Labrèche, F., B. Roberge, A. Yennek, NJ Caron, and J.-F. Bussières. "1508 Is hospital sanitation personnel exposed to antineoplastic agents?" In 32nd Triennial Congress of the International Commission on Occupational Health (ICOH), Dublin, Ireland, 29th April to 4th May 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/oemed-2018-icohabstracts.923.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Silva, Sâmela Maria de Oliveira, Manuelle de Araujo Holanda, Thaísa Mirella da Silva, Clebiana Alves e. silva Diniz, and Suzana Maria de Oliveira Costa Meneses. "Role of oncological nursing in stroke of antineoplastic drugs." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-044.

Texte intégral
Résumé :
Abstract Exposure to antineoplastic drugs poses a potential risk to the health of professionals who handle, administer and dispose of them. The risk of harmful effects arising from exposure to the cytotoxic properties of antineoplastic agents is not restricted to patients, and health professionals may also experience cellular and clinical changes related to occupational exposure to these substances. Professional exposure can occur at any time during the handling of chemotherapy, whether in preparation, administration or disposal.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Bradley, Cathy J., and Marcelo Coca Perraillon. "Abstract PR10: Fewer rural cancer patients treated with antineoplastic agents." In Abstracts: Eleventh AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 2-5, 2018; New Orleans, LA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp18-pr10.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Trendowski, Matthew, Timothy D. Christen, Christopher Acquafondata, and Thomas P. Fondy. "Abstract 3802: Evaluation of microfilament-directed cytochalasins as novel antineoplastic agents." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3802.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Escudero-Vilaplana, V., R. Collado-Borrell, A. Giménez-Manzorro, et al. "CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.162.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Kulemina, Lidia V., Kevin Morgan, Daniil Shabashvili, Carmen Allegra, Min Chen, and Maria Zajac-Kaye. "Abstract 3892: Anti-cooperative allosteric inhibitors of thymidylate synthase as novel antineoplastic agents." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3892.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Narrillos-Moraza, A., V. Escudero-Vilaplana, R. Collado-Borrell, et al. "5PSQ-048 Analysis of drug interactions between oral antineoplastic agents and concurrent medications." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.365.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Rodriguez, A., X. Fernández, A. Arderiu, et al. "1ISG-003 Impact of telepharmacy and community pharmacy remote-dispensing on patients on oral antineoplastic agents." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "Antineoplastic agents"

1

Antineoplastic agents - occupational hazards in hospitals. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2004. http://dx.doi.org/10.26616/nioshpub2004102.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Vous pouvez également être intéressé par les bibliographies sur le sujet « Antineoplastic agents » pour d’autres types de sources :
Articles de revues Thèses Livres
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie